Concise review: Cancer stem cells: In vitro models

Stem Cells

Volumn 30, Issue 2, 2012, Pages 95-99

  Mather, Jennie Powell ^a  

^a Analytical Sciences   (United States)

Author keywords

Cancer stem cells; In vitro culture; Models; Stem cell plasticity

Indexed keywords

CELL MARKER; CELL SURFACE PROTEIN; TUMOR MARKER;

BIOASSAY; CANCER BIOLOGY; CANCER GROWTH; CANCER STEM CELL; CARCINOGENICITY; CELL ASSAY; CELL GROWTH; CELL INTERACTION; CELL ISOLATION; CELL RENEWAL; CELL SELECTION; CELL SUBPOPULATION; CELL SURFACE; CELL TRANSFORMATION; CULTURE MEDIUM; CYTOLOGY; DNA MODIFICATION; GENETIC MANIPULATION; HUMAN; HYPOTHESIS; IN VITRO STUDY; NONHUMAN; ONCOLOGY; PHENOTYPE; REVIEW; STEM CELL; TUMOR MICROENVIRONMENT; TUMOR RECURRENCE; ANIMAL; BIOLOGICAL MODEL; CELL PROLIFERATION; CULTURE TECHNIQUE; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL CULTURE;

ANIMALS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; NEOPLASTIC STEM CELLS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84856089677     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.774     Document Type: Review

References (59)

1. Clevers H. The cancer stem cell: Premises, promises and challenges. Nat Med 2011;17:313-319.
2. Dick JE. Stem cell concepts renew cancer research. Blood 2008;112: 4793-4807.
3. Li H, Tang DG. Prostate cancer stem cells and their potential roles in metastasis. J Surg Oncol 2011;103:558-562.
4. Merlos-Suárez A, Barriga FM, Jung P et al. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 2011;8:511-524.
5. Medema JP, Vermeulen L. Microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Nature 2011;474:318-326.
6. Bissell MJ, Hines WC. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med 2011;17:320-329.
7. Bissell MJ, Labarge MA. Context, tissue plasticity, and cancer: Are tumor stem cells also regulated by the microenvironment?Cancer Cell 2005;7:17-23. (Pubitemid 40126379)
8. Liu S, Ginestier C, Ou SJ et al. Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res 2011;71:614-624.
9. Clarke MF, Dick JE, Dirks PB et al. Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006;66:9339-9344.
10. Sarry J-E, Murphy K, Perry R et al. Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/ SCID/IL2Rcc-deficient mice. J Clin Invest 2011;121:384-395.
11. Li C, Heidt DG, Dalerba P et al. Identification of pancreatic cancer stem cells. Cancer Res 2007;67:1030-1037.
12. Ricci-Vitiani L, Lombardi DG, Pilozzi E et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007;445:111-115. (Pubitemid 46067311)
13. Vermeulen L, Todaro M, de Sousa Mello F et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci USA 2008;105:13427-13432.
14. Charafe-Jauffret E, Ginestier C, Iovino F et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res 2009;69:1302-1313.
15. Eramo A, Lotti F, Sette G et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 2008; 15:504-514. (Pubitemid 351267301)
16. Wang J, Sakariassen PÄ, Tsinkalovsky O et al. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer 2008;122:761-768.
17. Pollard SM, Yoshikawa K, Clarke ID et al. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 2009;4: 568-580.
18. Quintana E, Shackleton M, Foster HR et al. Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 2010;18:510-523.
19. Girouard SD, Murphy GF. Melanoma stem cells: Not rare, but well done. Lab Invest 2011;91:647-664.
20. Chaffer C, Brueckmann I, Scheel C. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci USA 2011;108:7950-7955.
21. Iliopoulos D, Hirsch H, Wang G. Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion. Proc Natl Acad Sci USA 2011;108:1397-1402.
22. Lander AD. The 'stem cell' concept: Is it holding us back?J Biol 2009;8:70.
23. Natarajan TG, FitzGerald KT. Markers in normal and cancer stem cells. Cancer Biomark 2007;3:211-231. (Pubitemid 351492646)
24. Bidlingmaier S, Zhu X, Liu B. The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J Mol Med 2008;86:1025-1032.
25. Moreb JS. Aldehyde dehydrogenase as a marker for stem cells. Curr Stem Cell Res Ther 2008;3:237-246.
26. Douville J, Beaulieu R, Balicki D. ALDH1 as a functional marker of cancer stem and progenitor cells. Stem Cells Dev 2009;18:17-26.
27. Barker N, Ridgway RA, van Es JH et al. Crypt stem cells as the cells-of- origin of intestinal cancer. Nature 2009;457:608-612.
28. Phesse TJ, Clarke AR. Normal stem cells in cancer prone epithelial tissues. Br J Cancer 2009;100:221-227.
29. Morrison SJ, Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 2006;441:1068-1074. (Pubitemid 43990718)
30. Neumuller RA, Knoblich JA. Dividing cellular asymmetry: Asymmetric cell division and its implications for stem cells and cancer. Genes Dev 2009;23:2675-2699.
31. Lombardo Y, Scopelliti A, Cammareri P et al. Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. Gastroenterology 2011;140:297-309.
32. Ginestier C, Wicinski J, Cervera N et al. Retinoid signaling regulates breast cancer stem cell differentiation. Cell Cycle 2009;8:3297-3302.
33. Kern SE, Shibata D. The fuzzy math of solid tumor stem cells: A perspective. Cancer Res 2007;67:8985-8988. (Pubitemid 47535878)
34. Wicha MS. Cancer stem cell heterogeneity in hereditary breast cancer. Breast Cancer Res 2008;10:105.
35. Rodríguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nature 2011;17:330-339.
36. Leder K, Holland EC, Michor F. The therapeutic implications of plasticity of the cancer stem cell phenotype. PLoS ONE 2010;5:e14366.
37. Fang DD, Kim YJ, Lee CN et al. Expansion of CD133+ colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery. Br J Cancer 2010;102:1265-1275.
38. Yeung TM, Gandhi SC, Wilding JL et al. Cancer stem cells from colorectal cancer-derived cell lines. Proc Natl Acad Sci USA 2010;107:3722-3727.
39. Li H, Chen X, Calhoun-Davis T et al. PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells. Cancer Res 2008;68:1820-1825. (Pubitemid 351416567)
40. Ince TA, Richardson AL, Bell GW et al. Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes. Cancer Cell 2007;12:160-170. (Pubitemid 47199120)
41. Mani SA, Guo W, Liao M-J et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008;133:704-715. (Pubitemid 351636299)
42. Roberts PE. Isolation and establishment of human tumor stem cells. Methods Cell Biol 2008;86:325-342.
43. Lee J, Kotliarova S, Kotliarov Y et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006;9:391-403. (Pubitemid 43668737)
44. Mather JP (ed). Stem cell culture-methods in cell biology. San Diego, CA: Academic Press, Elsevier, vol. 86, 2008; pp 1-254.
45. Loo DT, Fuquay JI, Rawson CL, Barnes DW. Extended culture of mouse embryo cells without senescence: Inhibition by serum. Science 1987;236:200-202. (Pubitemid 17061040)
46. Masramon L, Vendrell E, Tarafa G et al. Genetic instability and divergence of clonal populations in colon cancer cells in vitro. J Cell Sci 2006;119:1477-1482. (Pubitemid 43732976)
47. Miki J, Furusato B, Li H et al. Identification of putative stem cell markers, CD133 And CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res 2007; 67:3153-3161. (Pubitemid 46724852)
48. Pirozzi G, Tirino V, Camerlingo R et al. Epithelial to mesenchymal transition by TGFβ-1 induction increases stemness characteristics in primary non small cell lung cancer cell line. PLoS ONE 2011;6: e21548.
49. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat Rev Cancer 2009;9:265-273.
50. Li R, Mather JP. Culture of pluripotent neural epithelial progenitor cells from e9 rat embryo. Methods Cell Biol 2008;86:227-240.
51. Schmelzer E, Wauthier E, Reid LM. The phenotypes of pluripotent human hepatic progenitors. Stem Cells 2006;24:1852-1858. (Pubitemid 44474161)
52. Baiocchi M, Biffoni M, Ricci-Vitiani L et al. New models for cancer research: Human cancer stem cell xenografts. Curr Opin Pharmacol 2010;10:380-384.
53. Gupta PB, Onder TT, Jiang G et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009;138:1-15.
54. Mather JP, Fieger C, Liang T et al. A stem cell-based platform for the discovery and development of anti-tumor therapeutic antibodies to novel targets. In: Little M, ed. Recombinant Antibodies for Immunotherapy, Cambridge University Press: NY, NY, 2009;313-335.
55. Gupta PB, Fillmore CM, Jiang G et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 2011;146:633-644.
56. Li F, Tiede B, Massagué J, Kang Y. Beyond tumorigenesis: Cancer stem cells in metastasis. Cell Res 2007;17:3-14. (Pubitemid 46096419)
57. Anderson EC, Hessman C, Levin TG et al. The role of colorectal cancer stem cells in metastatic disease and therapeutic response. Cancers 2011;3:319-339.
58. Di Franco S, Mancuso P, Benfante A et al. Colon cancer stem cells: Bench-to-Bedside - New therapeutical approaches in clinical oncology for disease breakdown. Cancers 2011;3:1957-1974.
59. Sottoriva A, Vermeulen L, Tavaré S. Modeling evolutionary dynamics of epigenetic mutations in hierarchically organized tumors. PLoS Comput Biol 2011;7:e1001132.